164 related articles for article (PubMed ID: 30584448)
1. Contributions and Implications of the Tehran Lipid and Glucose Study.
Azizi F; Takyar M; Zadeh-Vakili A
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84792. PubMed ID: 30584448
[TBL] [Abstract][Full Text] [Related]
2. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II.
Azizi F; Ghanbarian A; Momenan AA; Hadaegh F; Mirmiran P; Hedayati M; Mehrabi Y; Zahedi-Asl S;
Trials; 2009 Jan; 10():5. PubMed ID: 19166627
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study.
Khalili D; Azizi F; Asgari S; Zadeh-Vakili A; Momenan AA; Ghanbarian A; Eskandari F; Sheikholeslami F; Hadaegh F
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84748. PubMed ID: 30584434
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Physical Activity on Non-communicable Diseases: Findings from 20 Years of the Tehran Lipid and Glucose Study.
Sheikholeslami S; Ghanbarian A; Azizi F
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84740. PubMed ID: 30584431
[TBL] [Abstract][Full Text] [Related]
5. Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study.
Azizi F; Zadeh-Vakili A; Takyar M
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84777. PubMed ID: 30584442
[TBL] [Abstract][Full Text] [Related]
6. The 10-year trend of adult diabetes, prediabetes and associated risk factors in Tehran: Phases 1 and 4 of Tehran Lipid and Glucose Study.
Mahtab N; Farzad H; Mohsen B; Nakisa D
Diabetes Metab Syndr; 2017; 11(3):183-187. PubMed ID: 27666004
[TBL] [Abstract][Full Text] [Related]
7. Bibliometric overview of the Tehran Lipid and Glucose Study (TLGS) publications from 2000 to 2022.
Rezaeizadeh F; Ghazbani A; Nouri M; Bahadoran Z; Mansourzadeh MJ; Khalili D
J Diabetes Metab Disord; 2024 Jun; 23(1):343-351. PubMed ID: 38932887
[TBL] [Abstract][Full Text] [Related]
8. Biochemical Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study.
Hedayati M; Daneshpour MS; Zarkesh M; Zarif Yeganeh M; Sheikholeslami S; Faam B; Azizi F
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84783. PubMed ID: 30584444
[TBL] [Abstract][Full Text] [Related]
9. Effect of nutrition intervention on non-communicable disease risk factors among Tehranian adults: Tehran Lipid and Glucose Study.
Mirmiran P; Ramezankhani A; Hekmatdoost A; Azizi F
Ann Nutr Metab; 2008; 52(2):91-5. PubMed ID: 18349527
[TBL] [Abstract][Full Text] [Related]
10. Nutritional knowledge, attitude and practice of Tehranian adults and their relation to serum lipid and lipoproteins: Tehran lipid and glucose study.
Mirmiran P; Mohammadi-Nasrabadi F; Omidvar N; Hosseini-Esfahani F; Hamayeli-Mehrabani H; Mehrabi Y; Azizi F
Ann Nutr Metab; 2010; 56(3):233-40. PubMed ID: 20375546
[TBL] [Abstract][Full Text] [Related]
11. Predisposing factors of long-term responsiveness in a cardio-metabolic cohort: Tehran Lipid and Glucose Study.
Cheraghi L; Amiri P; Vahedi-Notash G; Jalali-Farahani S; Khalili D; Azizi F
BMC Med Res Methodol; 2021 Aug; 21(1):161. PubMed ID: 34372764
[TBL] [Abstract][Full Text] [Related]
12. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.
Rabani S; Sardarinia M; Akbarpour S; Azizi F; Khalili D; Hadaegh F
PLoS One; 2018; 13(5):e0195543. PubMed ID: 29768511
[TBL] [Abstract][Full Text] [Related]
13. Effects of a Healthy Lifestyle Education on the Incidence of Metabolic Syndrome in Children during a 13-Year Follow-up.
Jalali-Farahani S; Amiri P; Akbar HM; Cheraghi L; Karimi M; Azizi F
Int J Behav Med; 2018 Feb; 25(1):131-140. PubMed ID: 28795355
[TBL] [Abstract][Full Text] [Related]
14. Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study.
Parizadeh D; Momenan AA; Amouzegar A; Azizi F; Hadaegh F
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84738. PubMed ID: 30584430
[TBL] [Abstract][Full Text] [Related]
15. Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population.
Ayubi E; Khalili D; Delpisheh A; Hadaegh F; Azizi F
J Diabetes; 2015 Nov; 7(6):830-8. PubMed ID: 25492310
[TBL] [Abstract][Full Text] [Related]
16. Genetic Identification for Non-Communicable Disease: Findings from 20 Years of the Tehran Lipid and Glucose Study.
Daneshpour MS; Hedayati M; Sedaghati-Khayat B; Guity K; Zarkesh M; Akbarzadeh M; Javanrooh N; Zadeh-Vakili A; Azizi F
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84744. PubMed ID: 30584432
[TBL] [Abstract][Full Text] [Related]
17. Reproductive Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study.
Ramezani Tehrani F; Behboudi-Gandevani S; Rostami Dovom M; Farahmand M; Minooee S; Noroozzadeh M; Amiri M; Nazarpour S; Azizi F
Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84786. PubMed ID: 30584446
[TBL] [Abstract][Full Text] [Related]
18. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
Bozorgmanesh M; Hadaegh F; Azizi F
Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
[TBL] [Abstract][Full Text] [Related]
19. Risk of hypertension in school-aged children undergoing a long-term community-based lifestyle intervention: Tehran Lipid and Glucose Study.
Mansouri-Tehrani MM; Amiri P; Cheraghi L; Masihay-Akbar H; Mirmiran P; Azizi F
Prev Med; 2021 Dec; 153():106799. PubMed ID: 34506814
[TBL] [Abstract][Full Text] [Related]
20. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
